1.
CRISPR-Based Gene Therapy for Type 2 Diabetic Neuropathy. Eur. J. Public Health Environ. Res. [Internet]. 2026 May 21 [cited 2026 Jun. 21];2(1):120-7. Available from: https://pinnaclepubs.com/index.php/EJPHER/article/view/756